Fidelity D & D Bancorp Inc (FDBC) 32.0000 $FDBC Fidelity

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Fidelity D & D Bancorp Inc (FDBC) 32.0000 $FDBC

Fidelity D & D Bancorp, Inc. Increases Second Quarter 2016 Dividend
GlobeNewswire - Wed May 04, 12:47PM CDT
The Board of Directors of Fidelity D & D Bancorp, Inc. (OTCBB:FDBC), parent company of The Fidelity Deposit and Discount Bank, announce their declaration of the Company's second quarter dividend of $0.29 per share, a 7% increase above the previous quarterly payment of $0.27 per share. The dividend is payable June 10, 2016 to shareholders of record at the close of business on May 20, 2016.

Fidelity D & D Bancorp, Inc. Reports Better First Quarter 2016 Financial Results
GlobeNewswire - Wed Apr 27, 10:09AM CDT
Fidelity D & D Bancorp, Inc., (OTCBB:FDBC), parent company of The Fidelity Deposit and Discount Bank, announced net income for the quarter ended March 31, 2016 of $1.7 million, an improvement of over $0.1 million, or 8%, compared to $1.6 million for the first quarter of 2015. Higher revenue more than offset the increase in non-interest expenses, when compared to the first quarter of 2015. Earnings per share on a diluted basis for the quarter were $0.69 and $0.64 for the three months ended March 31, 2016 and 2015, respectively.

Fidelity D & D Bancorp, Inc. Reports Improved 2015 Financial Results
GlobeNewswire - Wed Feb 03, 9:47AM CST
Fidelity D & D Bancorp, Inc. (OTCBB:FDBC), parent company of The Fidelity Deposit and Discount Bank, announces net income for the year ended December 31, 2015 of $7.1 million, or $2.90 diluted earnings per share, a 12% increase compared to net income for the year ended December 31, 2014 of $6.4 million, or $2.62 diluted earnings per share. The increase resulted primarily from improving revenue by $1.6 million, or 7%, more net interest income earned plus the $0.2 million more other income. Earnings improvement resulted from strategic growth attributed to a relationship management strategy producing $52.1 million growth in annual average earning assets. This growth was funded by a $57.0 million increase in average deposit balances plus a $4.8 million average balance increase of shareholder's equity, partially offset by a $10.1 million reduction in the combined average borrowings and debt level, compared to the prior year. This revenue supported the $1.3 million upturn within other expenses from increases in salaries and benefits, marketing, and professional services. Furthermore, the Company incurred a $0.6 million pre-payment penalty expense, $0.4 million after tax, on a $10 million early pay-off of long-term debt in June 2015. Also during the 2015 second quarter, an IRS audit concluded with a tax loss adjustment that resulted in a $0.4 million credit to income taxes. The return on average assets (ROA) was 1.00% for 2015 and 0.96% for the 2014 year. Return on average equity (ROE) was 9.55% for 2015 and 9.12% for the 2014 year.

Fidelity D & D Bancorp declares Q4 2015 and 2015 bonus dividend of USD0.27 and USD0.10 per share
M2 - Thu Nov 05, 3:32AM CST
Fidelity D & D Bancorp In (OTC BB:FDBC) reported on Wednesday that its board of directors authorised a fourth quarter dividend of USD0.27 per share together with a 2015 bonus dividend of USD0.10 per share.

Fidelity D & D Bancorp, Inc. Fourth Quarter 2015 Dividend and 2015 $0.10 Bonus
PR Newswire - Wed Nov 04, 4:19PM CST
The Board of Directors of Fidelity D & D Bancorp, Inc. (OTC Bulletin Board: FDBC), parent company of The Fidelity Deposit and Discount Bank, announce their declaration of the Company's fourth quarter dividend of $0.27 per share plus a 2015 bonus dividend of $0.10 per share. The Company's successful growth lead the 2015 year-to-date net income above expected pace, at 12% above prior years' net income level. For the third consecutive year, the Board declared a one-time bonus payment as a means to share the Company's success with its' dedicated shareholders.

Fidelity D & D Bancorp, Inc. Reports Third Quarter 2015 Financial Results
GlobeNewswire - Thu Oct 29, 12:38PM CDT
Fidelity D & D Bancorp, Inc. (OTCBB:FDBC), parent company of The Fidelity Deposit and Discount Bank, announced net income for the quarter ended September 30, 2015 of $1.9 million, a $0.3 million, or 18%, increase compared to the same 2014 quarter. Earnings improvement resulted from strategic growth which expanded net interest income by 8%. The Company attributed its successful growth and net interest income improvement to its relationship management strategy with $62.6 million growth in quarterly average earning assets. This growth was funded by a $76.9 million increase in average deposit balances plus a $4.0 million average balance expansion of shareholder's equity, partially offset by a $20.3 million reduction in the combined average borrowings and debt level, compared to the prior year third quarter. Additional operating expense was incurred primarily from an increase in both salaries and benefits, and premises and equipment costs, which was offset by more gains on loan sales and loan service charges compared to the previous year's third quarter. The return on average assets (ROA) was 1.06% for the third quarter of 2015 and 0.98% for the same period of 2014. Earnings per share on a diluted basis were $0.79 and $0.67 for the three months ended September 30, 2015 and 2014, respectively.

Fidelity D & D Bancorp declares Q3 2015 dividend of USD0.27 per share
M2 - Thu Aug 06, 5:50AM CDT
Fidelity D & D Bancorp Inc (OTC BB:FDBC) released on Wednesday a third quarter dividend of USD0.27 per share.

Fidelity D & D Bancorp, Inc. Third Quarter 2015 Dividend
PR Newswire - Wed Aug 05, 2:22PM CDT
The Board of Directors of Fidelity D & D Bancorp, Inc. (OTC Bulletin Board: FDBC), parent company of The Fidelity Deposit and Discount Bank, announce their declaration of the Company's third quarter dividend of $0.27 per share. The dividend is payable September 10, 2015 to shareholders of record at the close of business on August 20, 2015.

Fidelity D & D Bancorp, Inc. Reports Second Quarter 2015 Financial Results
PR Newswire - Wed Jul 29, 11:53AM CDT
Fidelity D & D Bancorp, Inc. (OTC Bulletin Board: FDBC), parent company of The Fidelity Deposit and Discount Bank, announced net income for the quarter ended June 30, 2015 of $1.8 million, a $0.2 million, or 9%, increase compared to the same 2014 quarter. Earnings improvement resulted from planned growth which expanded net interest income by 7%. Additional operating expense was incurred primarily from a penalty fee on the early payoff of long-term debt, which was offset by the reduction in provision for loan losses and recognized credit for income taxes, compared to the previous year's second quarter. The Company attributed its successful growth and net interest income improvement to its relationship management strategy with a $53 million growth in quarterly average earning assets. This growth was funded by a $49 million increase in average deposit balances plus a $5 million average balance expansion of shareholder's equity, compared to the prior year second quarter. The return on average assets (ROA) was 1.01% for the second quarter of 2015 and 2014. Earnings per share on a diluted basis were $0.73 and $0.67 for the three months ended June 30, 2015 and 2014, respectively.

Fidelity Deposit & Discount Bank Recognized for Outstanding Community Service, Receives Pillars of the Community Award
BusinessWire - Tue Jun 02, 11:35AM CDT
Fidelity Deposit & Discount Bank was presented today with the prestigious FHLBank Pittsburgh Pillars of the Community Award in recognition of the bank's commitment to community revitalization. The Pillars award is FHLBank's highest organizational honor and is presented annually to select FHLBank members.

Fidelity D & D Bancorp announces 8% higher dividend of USD0.27 per share for Q2 2015
M2 - Thu May 07, 3:06AM CDT
Fidelity D & D Bancorp Inc (OTC BB:FDBC) disclosed on Wednesday that its board of directors authorised the second quarter dividend of USD0.27 per share, up 8% over the previous quarterly payment.

Fidelity D & D Bancorp, Inc. Reports First Quarter 2015 Financial Results
PR Newswire - Wed Apr 29, 2:36PM CDT
Fidelity D & D Bancorp, Inc., (OTC Bulletin Board: FDBC), parent company of The Fidelity Deposit and Discount Bank, announced net income for the quarter ended March 31, 2015 of $1.6 million, an improvement of $0.1 million, or 8%, compared to $1.5 million for the first quarter of 2014. Net interest income growth, along with a lower provision for loan losses, more than offset the non-interest expenses increase, when compared to the prior year first quarter. Earnings per share on a diluted basis for the quarter were $0.63 and $0.61 for the three months ended March 31, 2015 and 2014, respectively.

Fidelity D&D Bancorp, Inc. Announces New Chief Business Development Officer
PR Newswire - Tue Apr 14, 2:39PM CDT
The Board of Directors of Fidelity D&D Bancorp, Inc., (OTC Bulletin Board: FDBC) parent company of the Fidelity Deposit and Discount Bank announced that Michael J. Pacyna, Jr. has joined the bank in the position of Executive Vice President & Chief Business Development Officer.

Fidelity D & D Bancorp declares dividend of USD0.25 per share for Q1 2015
M2 - Thu Feb 05, 6:54AM CST
The board of directors of Fidelity D & D Bancorp Inc (OTC BB:FDBC), the parent company of the Fidelity Deposit and Discount Bank, approved a dividend of USD0.25 per share, the company reported on Wednesday.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 397

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
BAIC FOTON Eyes African Market with Strategic Moves

Updated Category News Views 149

Revving Up for Africa Alright, gearheads and number-crunchers, strap in. BAIC FOTON is making headlines again, and this time they’re zooming right into Africa—like they're claiming pole position on a circuit that's been ignored by many. They’re calling it a “Drive to Great!” but what does that mean for us investors who aren’t just in it for the entertainment?...

Continue Reading
RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 205

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 606

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
Dr. Boonipat Inspires Future Women Surgeons at Texas Tech

Updated Category News Views 288

Sowing Surgical Seeds in Lubbock In Lubbock, Texas, something meaningful unfolded—an event the big market players would hardly blink at, but a significant step for the future of medicine. Led by Dr. Thanapoom "Mo" Boonipat, the founder of FacePlus Plastic Surgery Institute, a unique suturing workshop provided premed students at Texas Tech University hands-on experience...

Continue Reading
Gildan Activewear Faces Legal Battle Over Alleged Fraud

Updated Category News Views 196

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 245

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 258

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Firefox Champions Privacy with Iconic Internet Campaign

Updated Category News Views 223

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Continue Reading
Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 322

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading

Top 5 Most Recently Viewed Articles

Care Synergy and RCC Medical Equipment Launch New Partnership

Updated Category News Views 320

Care Synergy and RCC Medical Equipment Form Joint Venture In an exciting development for healthcare services, Care Synergy and RCC Medical Equipment Co. have announced their plans to create a strategic joint venture aimed at improving healthcare delivery in the Colorado Front Range region. This partnership will leverage the strengths of both organizations to provide...

Continue Reading
Revitalizing China's Tourism with High-Tech Cultural Experiences

Updated Category News Views 217

Revitalizing China's Tourism Through High-Tech Cultural Experiences China's tourism industry is undergoing an exciting transformation, fueled by the innovative use of advanced technology paired with its rich cultural heritage. A remarkable example is in Chongqing Municipality, where the city's skyline has become a vibrant showcase of cultural stories, highlighted by...

Continue Reading
Intriguing Insights into United States Steel Options Trades

Updated Category News Views 111

Analyzing Unusual Options Activity in United States Steel Recently, there's been notable market activity where investors with deep pockets are taking a more bearish stance on United States Steel (X). This trend is definitely something for retail traders to pay attention to, especially when navigating the complexities of the stock market. Today's options history unveiled...

Continue Reading
Mesoblast's Operational Highlights and Financial Insights Unveiled

Updated Category News Views 185

Mesoblast Limited's Webcast for Financial Results On a recent occasion, Mesoblast Limited (NASDAQ: MESO; ASX: MSB), a pioneer in allogeneic cellular medicine for inflammatory diseases, announced a webcast to delve into their operational achievements and financial metrics for the half year concluding December 31, 2024. Details of the Webcast Event The engaging webcast is...

Continue Reading
Investors of DXC Technology Prepare for Class Action Lawsuit

Updated Category News Views 77

Investors of DXC Technology Company Take Action In recent months, investors who purchased common stock from DXC Technology Company (NYSE: DXC) have been given a significant opportunity to participate in a class action lawsuit. This situation arises from allegations of securities fraud that are said to have affected many individuals who bought shares during specific key...

Continue Reading